Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

NUDT11 Inhibitors

NUDT11 inhibitors encompass a range of compounds that can influence the activity of NUDT11, a Nudix hydrolase enzyme. These inhibitors can exert their effects by interacting with cellular processes and pathways related to the enzyme's function, thereby modulating its activity. The identification and characterization of these inhibitors rely on an understanding of NUDT11's role in hydrolyzing dinucleoside polyphosphates and its involvement in cellular signaling, stress responses, and nucleotide metabolism. Given the enzyme's participation in these critical cellular processes, the inhibitors can be designed or identified based on their ability to modulate these pathways either directly or indirectly. The development of NUDT11 inhibitors can utilize various approaches. One common method is the use of substrate analogs, where compounds structurally similar to the natural substrates of NUDT11 are used. These analogs can bind to the active site of the enzyme, effectively blocking its catalytic activity. Another approach involves the use of active site blockers, small molecules designed based on the enzyme's 3D structure, which bind to the active site and prevent substrate access. Allosteric inhibitors also play a significant role; these are molecules that bind to sites other than the active site, inducing conformational changes that reduce enzyme activity. High-throughput screening is another pivotal method, leveraging large chemical libraries to identify compounds that can modulate the activity of NUDT11. This approach allows for the discovery of unexpected compounds that may be effective. Furthermore, NUDT11 inhibitors can also include peptidomimetics, designed to mimic the interaction between NUDT11 and its substrates or protein partners. These molecules can interfere with the enzyme's function by mimicking or blocking its natural interactions. Additionally, natural product screening is employed to discover compounds found in natural sources that exhibit inhibitory effects on NUDT11. Computational modeling is increasingly used to predict the interaction between inhibitors and NUDT11, aiding in the design of more effective compounds. Finally, considering inhibitors effective against other Nudix hydrolases can be beneficial, given the shared structural or functional characteristics among family members. These diverse methods collectively contribute to the development of a robust class of NUDT11 inhibitors, each employing unique mechanisms to modulate the enzyme's activity within the cell.

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin, as an mTOR modulator, could possibly inhibit NUDT11 by affecting cell growth and proliferation pathways, influencing the cellular context in which NUDT11 operates.